Catheter Precision, Inc. (VTAK)

Profile

Full Name

Catheter Precision, Inc.

Ticker Symbol

NYSEAmerican: VTAK

Exchange

NYSE American

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

September 27, 2018

Indexes

Not included

Website

http://www.catheterprecision.com

Employees

22

Key Details

Price

$0.23(-4.17%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$420.00K(-4.98% YoY)

Annual EPS

-$6.68(+94.86% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.23
    VTAK price is $0.23

    30-Day Relative Volume

    0.03
    VTAK 30-day relative volume is 0.03

    Price Performance

    Price Most recent change

    -4.17%
    VTAK price was down -4.17% on Jul 3, 2025

    Price YTD change

    -48.89%
    VTAK price is down -48.89% since January 1st

    Price 1-year change

    -93.95%
    VTAK price is down -93.95% year-on-year

    Price 3-year change

    -99.85%
    VTAK price is down -99.85% over the past 3 years

    Price Range

    Price All-time high

    $275000.00
    VTAK price is currently -100.00% below its historical high of $275000.00

    Price 3-year low

    $0.16
    VTAK price is currently +43.75% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.53M
    VTAK market capitalization is $2.53 million

    Market cap 3-year change

    -74.69%
    VTAK market capitalization is down -74.69% over the past 3 years

    Market cap All-time high

    $250.00M
    VTAK market capitalization is currently -98.99% below its historical high of $250.00 million

    Market cap sector rank

    6.56%
    VTAK market capitalization is higher than 6.56% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1213.46%
    VTAK shares outstanding is up +1213.46% year-on-year

    Shares Outstanding 3-Year Change

    +16954.64%
    VTAK shares outstanding is up +16954.64% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.42
    VTAK beta is 0.42

    200-day SMA

    $0.38
    VTAK price is currently -39.58% below its 200-day simple moving average

    50-day SMA

    $0.27
    VTAK price is currently -15.29% below its 50-day simple moving average

    RSI

    44.11
    VTAK 14-day relative strength index is 44.11

    Volume

    0.03
    VTAK 30-day relative volume is 0.03

    ATR

    $0.04
    VTAK average true range is $0.04

    10-day Historical Volatility

    78.89%
    VTAK 10-day historical volatility is 78.89%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $420.00K
    VTAK annual revenue is $420.00 thousand

    Revenue Analysts estimate

    $3.82M
    VTAK annual revenue is currently -89.01% lower than the consensus analysts' forecast

    Revenue 1-year change

    -4.98%
    VTAK annual revenue is down -4.98% year-on-year

    Revenue Sector rank

    8.38%
    VTAK annual revenue is higher than 8.38% of companies in Healthcare sector

    EPS

    EPS

    -$6.68
    VTAK annual earnings per share is -$6.68

    EPS Analysts estimate

    -$0.63
    VTAK annual earnings per share is currently +960.32% higher than the consensus analysts' forecast

    EPS 1-year change

    +94.86%
    VTAK annual earnings per share is up +94.86% year-on-year

    EPS Sector rank

    16.24%
    VTAK annual earnings per share is higher than 16.24% of companies in Healthcare sector

    Profit

    Gross profit

    $378.00K
    VTAK annual gross profit is $378.00 thousand

    Gross margin

    90.00%
    VTAK annual gross profit margin is 90.00%

    Operating profit

    -$11.24M
    VTAK annual operating income is -$11.24 million

    Operating margin

    -2676.90%
    VTAK annual operating profit margin is -2676.90%

    Net income

    -$16.64M
    VTAK annual net profit is -$16.64 million

    Net margin

    -3962.62%
    VTAK annual net profit margin is -3962.62%

    Expenses

    Total expenses

    $11.66M
    VTAK annual total expenses is $11.66 million

    Operating expenses

    $11.62M
    VTAK annual total operating expenses is $11.62 million

    Cost of goods sold

    $42.00K
    VTAK annual cost of goods sold is $42.00 thousand

    Selling, general & administrative expenses

    $11.35M
    VTAK annual SGA is $11.35 million

    Depreciation and amortization

    $2.11M
    VTAK annual depreciation & amortization is $2.11 million

    Interest expense

    $91.00K
    VTAK annual interest expense is $91.00 thousand

    Income tax

    $3.14M
    VTAK annual income tax is $3.14 million

    EBIT & EBITDA

    EBIT

    -$13.41M
    VTAK annual earnings before interest & taxes is -$13.41 million

    EBITDA

    -$11.30M
    VTAK annual EBITDA is -$11.30 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $27.77M
    VTAK annual total assets is $27.77 million

    Non current assets

    $24.48M
    VTAK annual long term assets is $24.48 million

    Current assets

    $3.29M
    VTAK annual total current assets is $3.29 million

    Cash and cash equivalents

    $2.87M
    VTAK annual cash & cash equivalents is $2.87 million

    Accounts receivable

    $70.00K
    VTAK annual accounts receivable is $70.00 thousand

    Inventory

    $33.00K
    VTAK annual inventory is $33.00 thousand

    Liabilities

    Total liabilities

    $16.01M
    VTAK annual total liabilities is $16.01 million

    Long term liabilities

    $13.93M
    VTAK annual total long term liabilities is $13.93 million

    Current liabilities

    $2.08M
    VTAK annual total current liabilities is $2.08 million

    Accounts payable

    $230.00K
    VTAK annual accounts payable is $230.00 thousand

    Debt

    Total debt

    $1.79M
    VTAK annual total debt is $1.79 million

    Total debt 1-year change

    +380.65%
    VTAK annual total debt is up +380.65% year-on-year

    Long term debt

    $1.51M
    VTAK annual long term debt is $1.51 million

    Short term debt

    $275.00K
    VTAK annual short term debt is $275.00 thousand

    Equity & Capital

    Shareholders equity

    $11.76M
    VTAK annual stockholders equity is $11.76 million

    Book value

    $11.76M
    VTAK annual book value is $11.76 million

    Retained earnings

    -$292.35M
    VTAK annual retained earnings is -$292.35 million

    Working capital

    $1.21M
    VTAK annual working capital is $1.21 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$9.27M
    VTAK annual cash flow from operations is -$9.27 million

    Cash from operations 1-year change

    +55.04%
    VTAK annual cash flow from operations is up +55.04% year-on-year

    Cash from investing

    -$67.00K
    VTAK annual cash flow from investing activities is -$67.00 thousand

    Cash from investing 1-year change

    -9.84%
    VTAK annual cash flow from investing activities is down -9.84% year-on-year

    Cash from financing

    $8.65M
    VTAK annual cash flow from financing activities is $8.65 million

    Cash from financing 1-year change

    +3.1%
    VTAK annual cash flow from financing activities is up +3.1% year-on-year

    CAPEX

    CAPEX

    $67.00K
    VTAK annual capital expenditures is $67.00 thousand

    CAPEX 1-year change

    -11.84%
    VTAK annual capital expenditures is down -11.84% year-on-year

    Free Cash Flow

    Free cash flow

    -$9.34M
    VTAK annual free cash flow is -$9.34 million

    Free cash flow 1-year change

    +54.88%
    VTAK annual free cash flow is up +54.88% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    90.00%
    VTAK annual gross profit margin is 90.00%

    Operating margin

    -2676.90%
    VTAK annual operating profit margin is -2676.90%

    Net margin

    -3962.62%
    VTAK annual net profit margin is -3962.62%

    ROA & ROE

    ROA

    -56.89%
    VTAK annual return on assets is -56.89%

    ROE

    -101.02%
    VTAK annual return on equity is -101.02%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    VTAK price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    VTAK price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.32
    VTAK price to book ratio is 0.32

    PB ratio Sector rank

    21.76%
    VTAK price to book ratio is higher than 21.76% of companies in Healthcare sector

    PS Ratio

    PS ratio

    5.27
    VTAK price to sales ratio is 5.27

    PS ratio Sector rank

    64.59%
    VTAK price to sales ratio is higher than 64.59% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $3.88M
    VTAK enterprise value is $3.88 million

    Enterprise value Sector rank

    16.46%
    VTAK enterprise value is higher than 16.46% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.33
    VTAK EV/EBITDA is -0.33

    EV/EBITDA Sector rank

    57.73%
    VTAK EV/EBITDA is higher than 57.73% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.58
    VTAK annual current ratio is 1.58

    Quick ratio

    1.56
    VTAK annual quick ratio is 1.56

    Leverage

    Debt to equity

    0.14
    VTAK annual debt to equity ratio is 0.14

    Interest coverage ratio

    -147.37
    VTAK annual interest coverage ratio is -147.37

    Risk & Stability

    Piotroski F-Score

    3
    VTAK piotroski f-score is 3

    Altman Z-Score

    -16.17
    VTAK altman z-score is -16.17

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with VTAK included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    Healthcare sector
    All stocks
    Ex Dividend dates calendar
    Small cap stocks
    • What is the ticker symbol for Catheter Precision, Inc.?
    • Does Catheter Precision, Inc. pay dividends?
    • What sector is Catheter Precision, Inc. in?
    • What industry is Catheter Precision, Inc. in?
    • What country is Catheter Precision, Inc. based in?
    • When did Catheter Precision, Inc. go public?
    • Is Catheter Precision, Inc. in the S&P 500?
    • Is Catheter Precision, Inc. in the NASDAQ 100?
    • Is Catheter Precision, Inc. in the Dow Jones?
    • When was Catheter Precision, Inc.'s last earnings report?
    • When does Catheter Precision, Inc. report earnings?

    What is the ticker symbol for Catheter Precision, Inc.?

    The ticker symbol for Catheter Precision, Inc. is NYSEAmerican:VTAK

    Does Catheter Precision, Inc. pay dividends?

    No, Catheter Precision, Inc. does not pay dividends

    What sector is Catheter Precision, Inc. in?

    Catheter Precision, Inc. is in the Healthcare sector

    What industry is Catheter Precision, Inc. in?

    Catheter Precision, Inc. is in the Medical Devices industry

    What country is Catheter Precision, Inc. based in?

    Catheter Precision, Inc. is headquartered in United States

    When did Catheter Precision, Inc. go public?

    Catheter Precision, Inc.'s initial public offering (IPO) was on September 27, 2018

    Is Catheter Precision, Inc. in the S&P 500?

    No, Catheter Precision, Inc. is not included in the S&P 500 index

    Is Catheter Precision, Inc. in the NASDAQ 100?

    No, Catheter Precision, Inc. is not included in the NASDAQ 100 index

    Is Catheter Precision, Inc. in the Dow Jones?

    No, Catheter Precision, Inc. is not included in the Dow Jones index

    When was Catheter Precision, Inc.'s last earnings report?

    Catheter Precision, Inc.'s most recent earnings report was on November 29, 2019

    When does Catheter Precision, Inc. report earnings?

    The date for Catheter Precision, Inc.'s next earnings report has not been announced yet
    On this page